Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.
Press releases published on June 16, 2025
X4 Pharmaceuticals Presents Positive Phase 2 Chronic Neutropenia Trial Data in Poster Presentations at the 30th Annual Congress of the European Hematology Association (EHA)
GlobeNewswire
·
June 16, 2025
Poster #1654 highlights clinically meaningful and durable increases in circulating neutrophils observed with mavorixafor treatment +/- G-CSF over 6-month study Poster #1669 highlights findings that investigators were willing and able to reduce injectable G …
Crinetics Pharmaceuticals to Host R&D Day on June 26, 2025
GlobeNewswire
·
June 16, 2025
SAN DIEGO, June 16, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that it will host an in-person and virtual R…
Slide Raises $25M Series A led by Base10 Partners to Accelerate Market Growth, Expands to Canada
GlobeNewswire
·
June 16, 2025
NORWALK, Conn., June 16, 2025 (GLOBE NEWSWIRE) -- Slide, the next-generation BCDR (Business Continuity and Disaster Recovery) platform purpose-built for MSPs, today announced it has raised $25 million in Series A funding. The round was led by Base10 …
Milestone Pharmaceuticals Submits Response to the FDA’s CRL for CARDAMYST (etripamil) Nasal Spray for PSVT Following Type A Meeting
GlobeNewswire
·
June 16, 2025
MONTREAL and CHARLOTTE, N.C., June 16, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today announced submission of its response to the U.S. Food and Drug Administration (FDA)’s Complete Response Letter (CRL) regarding its New Drug …
Windtree Announces Publication of Istaroxime Positive Phase 2 SEISMiC B Study
GlobeNewswire
·
June 16, 2025
The Phase 2 Istaroxime study was successful in multiple endpoints showing promise for how it may be utilized if approved in its targeted indications Primary endpoint of the study was met of increasing systolic blood pressure and demonstration of other …
Beyond Air Submits FDA PMA Supplement for Next Generation LungFit® PH
GlobeNewswire
·
June 16, 2025
LungFit PH II’s smaller, lightweight, transport-ready design is expected to open the entirety of the NO market Final design based upon substantial feedback from respiratory therapists across the country GARDEN CITY, N.Y., June 16, 2025 (GLOBE NEWSWIRE) -- …
Immuneering to Provide Updates from Phase 2a Clinical Trial of IMM-1-104 in First-Line Pancreatic Cancer Patients on Tuesday, June 17, 2025
GlobeNewswire
·
June 16, 2025
CAMBRIDGE, Mass., June 16, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company outpacing cancer to help patients outlive their disease, today announced that it will host a conference call and live webcast at 8 …
AgEagle Switzerland Facility Recommended for Prestigious ISO 9001 Certification
GlobeNewswire
·
June 16, 2025
Achievement demonstrates manufacturer’s drive for excellence in drone production Cheseaux-sur-Lausanne, Switzerland, June 16, 2025 (GLOBE NEWSWIRE) -- AgEagle Aerial Systems Inc. (NYSE:UAVS), a leading provider of advanced drone and aerial imaging …
Genius Group increases Bitcoin Treasury to 100 Bitcoin.
GlobeNewswire
·
June 16, 2025
SINGAPORE, June 16, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, today announced that further to the favorable ruling by the U.S. Court of Appeals …
Korea Smart Healthcare Association and SL Foundation Sign MOU for Development of Multimodal, AI, and Blockchain-Based Medical Platform
GlobeNewswire
·
June 16, 2025
Singapore, June 16, 2025 (GLOBE NEWSWIRE) -- On June 10, 2025, the Korea Smart Healthcare Association (Chairman: Ki-Jun Shim) and SL Foundation (CEO: Sang-Sub Gong) signed a Memorandum of Understanding (MOU) to form a strategic partnership aimed at …
FOXO TECHNOLOGIES INC. CREATES ACQUISITION VEHICLE AND APPOINTS NEW INTERIM CFO
GlobeNewswire
·
June 16, 2025
WEST PALM BEACH, FLORIDA, June 16, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”) today announced that it formed a new, wholly-owned subsidiary intended to be used to acquire identified acquisition targets …
ParaZero Demonstrates 50 Successful DropAir Deployments as Part of a Decisive Reproducibility Test
GlobeNewswire
·
June 16, 2025
Kfar Saba, Israel, June 16, 2025 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace company focused on safety systems for commercial unmanned aerial systems and counter UAS systems, today announced the …
DNMiner Launches AI-Powered Green Cloud Mining Platform to Revolutionize Sustainable Crypto Mining
GlobeNewswire
·
June 16, 2025
New York City, June 16, 2025 (GLOBE NEWSWIRE) -- DNMiner, a trailblazer in green cloud mining, today announces the launch of its groundbreaking AI-managed renewable-powered mining infrastructure, setting a new standard for sustainable cryptocurrency mining …
Onco360 Has Been Selected as a National Specialty Pharmacy Partner for IBTROZI™ (taletrectinib), Manufactured by Nuvation Bio Inc.
GlobeNewswire
·
June 16, 2025
LOUISVILLE, Ky., June 16, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Nuvation Bio Inc. for IBTROZI™ (taletrectinib), a kinase inhibitor approved for the treatment of …
Emory University and Micron Biomedical Launch First-in-Human Clinical Trial of Next-Generation Rotavirus Vaccine Delivered via Dissolvable Microarray Technology
GlobeNewswire
·
June 16, 2025
Trial represents first-ever CDC-sponsored clinical trial of vaccine delivered via “patch” technology and utilizes Micron’s first-in-class dissolvable microarray technology Research builds on Emory’s research on influenza vaccines self-administered via …
Caledonia Mining Corporation Plc: Utilisation of the block admission in respect of ATM Sales Agreement
GlobeNewswire
·
June 16, 2025
ST HELIER, Jersey, June 16, 2025 (GLOBE NEWSWIRE) -- In accordance with Rule 29 of the AIM Rules for Companies (“the AIM Rules”), Caledonia Mining Corporation Plc (“Caledonia” or “the Company”) (NYSE AMERICAN: CMCL; AIM: CMCL; VFEX: CMCL) gives below the …
NextCure and Simcere Zaiming Announce Strategic Partnership for a Novel Antibody-Drug Conjugate Targeting CDH6
GlobeNewswire
·
June 16, 2025
NextCure gains global rights to SIM0505 excluding greater China, where Simcere Zaiming will retain rights Phase 1 clinical trial ongoing for SIM0505 in China; U.S. Phase 1 clinical trial is expected to begin in the third quarter of 2025 Initial Phase 1 …
Ocugen, Inc. Announces U.S. FDA Clearance of Investigational New Drug Amendment to Initiate Phase 2/3 Pivotal Confirmatory Clinical Trial of OCU410ST—Modifier Gene Therapy Candidate for Stargardt Disease
GlobeNewswire
·
June 16, 2025
MALVERN, Pa., June 16, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared …
Mark Ford Joins Highway as Chief Capacity Officer
GlobeNewswire
·
June 16, 2025
DALLAS, June 16, 2025 (GLOBE NEWSWIRE) -- Highway announced today that Mark Ford will join the company as Chief Capacity Officer, a strategic addition to the executive team as the company accelerates growth and advances its long-term vision to redefine …
Jiangsu Hengrui Pharmaceuticals and Kailera Therapeutics Announce Clinical Data Presentations at the American Diabetes Association 85th Scientific Sessions
GlobeNewswire
·
June 16, 2025
– Hengrui to present six abstracts highlighting clinical progress of GLP-1/GIP dual receptor agonist HRS9531 (KAI-9531) and GLP-1 receptor agonist HRS-7535 (KAI-7535) in type 2 diabetes and obesity – JIANGSU, China and BOSTON, June 16, 2025 (GLOBE NEWSWIRE …